Barts Heart Centre St Bartholomew's Hospital London United Kingdom.
William Harvey Research InstituteQueen Mary University London London United Kingdom.
J Am Heart Assoc. 2021 Jun 15;10(12):e019610. doi: 10.1161/JAHA.120.019610. Epub 2021 May 31.
Background Recognizing the etiology of sudden cardiac arrest (SCA) has an enormous impact on the management of victims and their immediate families. A significant proportion of SCA survivors with a structurally normal heart are not offered a diagnosis and there is no clear consensus on the type and duration of follow-up. We aimed to assess the utility of a multidisciplinary approach in optimizing diagnosis of cardiac arrest etiology during follow-up. Methods and Results We retrospectively assessed 327 consecutive SCA survivors (mean age 61.9±16.2 years, 80% men) who underwent secondary prevention implantable cardioverter defibrillators between May 2015 and November 2018. The initial diagnosis was recorded at the time of admission and follow-up diagnosis was deduced from subsequent clinic records, investigations, and outcomes of multidisciplinary team meetings. Structural heart disease accounted for 282 (86%) of SCAs. Forty-five (14%) patients had a structurally normal heart and underwent comprehensive testing and follow-up (mean duration 93±52 weeks). On initial evaluation, 14/45 (31%) of these received a diagnosis, rising to 29/45 (64%) with serial reviews during follow-up. Discussion in multidisciplinary team meetings and imaging reassessment accounted for 47% of new diagnoses. No additional diagnoses were made beyond 96 weeks. Nineteen (5.8%) fatalities occurred in the entire cohort, exclusively in patients with structural heart disease. Conclusions Systematic comprehensive testing combined with multidisciplinary expert team review of SCA survivors without structural heart disease improves the yield and time to diagnosis compared with previously published studies. This approach has positive implications in the management of SCA survivors and their families.
明确心搏骤停(SCA)的病因对患者及其直系亲属的治疗具有重大影响。很大一部分结构正常心脏的 SCA 幸存者未获得明确诊断,并且对于随访的类型和持续时间尚无明确共识。我们旨在评估多学科方法在优化心搏骤停病因诊断中的作用。
我们回顾性评估了 2015 年 5 月至 2018 年 11 月间接受二级预防植入式心律转复除颤器的 327 例连续 SCA 幸存者(平均年龄 61.9±16.2 岁,80%为男性)。初始诊断记录在入院时,随访诊断从后续临床记录、检查和多学科团队会议的结果中推断出来。结构性心脏病占 282 例(86%)SCA 的病因。45 例(14%)患者的心脏结构正常,接受了全面检查和随访(平均随访时间 93±52 周)。在最初评估时,其中 14/45(31%)患者获得了诊断,在随访期间的系列评估中,这一比例上升至 29/45(64%)。多学科团队会议讨论和影像学再评估占新诊断的 47%。96 周后未再做出其他诊断。整个队列中发生了 19 例(5.8%)死亡事件,均发生在结构性心脏病患者中。
与之前发表的研究相比,系统全面的检查结合无结构性心脏病的 SCA 幸存者的多学科专家团队审查可提高诊断的阳性率和时间。这种方法对 SCA 幸存者及其家属的管理具有积极意义。